Hidden Cove Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Hidden Cove Wealth Management's ABBV Position: Q2 2026 in Review
Hidden Cove Wealth Management increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $79.4K and bringing the position to 2,600 shares worth $654K. The position accounts for 0.36% of the portfolio, ranked #52.
Hidden Cove Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hidden Cove Wealth Management held 2,600 shares of AbbVie worth $654K as of Q2 2026.
- Hidden Cove Wealth Management bought 369 AbbVie shares in Q2 2026, an estimated $79.4K.
- AbbVie made up 0.36% of Hidden Cove Wealth Management's portfolio in Q2 2026, its #52 holding.
- Hidden Cove Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
- 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hidden Cove Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.